Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Bharat Biotech

Focus On J&J, Pfizer COVID-19 Vaccine Pricing As India Permits Private Sales

As India permits private sales, prices for J&J and Pfizer’s COVID-19 vaccines will be watched closely. While demand is set to spike with age criteria for those eligible to receive the shots expanded, local manufacturers Serum Institute and Bharat Biotech are ramping up capacities with the government’s help.

India Coronavirus COVID-19

Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators

In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?

India Coronavirus COVID-19

Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators

In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?

India Coronavirus COVID-19

J&J, Pfizer To Gain As India Fast Tracks COVID-19 Vaccines Approved By Other Regulators

J&J and Pfizer should benefit from India’s unusual move to grant accelerated approvals minus a prior local bridging study for COVID-19 vaccines granted emergency use authorizations by certain regulators or on the WHO’s emergency use list. But while this seems like a prelude to permitting private sales, where will the supplies come from?

Policy & Regulation Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Chiron Behring Vaccines Pvt Ltd
UsernamePublicRestriction

Register